[ACRV] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -3.97%
YoY- -64.00%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
Revenue 0 0 0 0 -
PBT -22,441 -14,466 -9,198 -2,440 109.37%
Tax 0 -133 -377 -231 -
NP -22,441 -14,466 -8,821 -2,209 116.42%
Tax Rate - - - - -
Total Cost 22,441 14,466 8,821 2,209 116.42%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
EPS -0.59 -0.66 -0.47 -0.17 51.34%
EPS Diluted -0.59 -0.66 -0.47 -0.17 51.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.